image with a pad of paper with the words "regulatory affairs" written on it - this depicts patient guards regulatory services such as PRRC.

The Extended EU Regulations: Navigating the Path to Medical Device Compliance


In the fast-paced world of medical device manufacturing, regulatory standards are the bedrock of patient safety and product quality. Recently, the European Union has taken a significant step by extending Article 120 of the EU Regulation 2017/745 and EU Regulation 2017/746. This move has been made to address the mounting backlog of CE mark certifications and re-certifications within notified bodies. Theses are the entities responsible for ensuring that medical devices meet stringent quality and safety requirements before they reach the market. In this blog post, we’ll delve into the implications of this extension for medical device manufacturers and emphasize the critical importance of continued compliance.

Understanding the Extension: Clearing the Notified Body Backlog

The extension of Article 120 in both the EU Regulation 2017/745 and EU Regulation 2017/746 underscores the European Union’s commitment to maintaining the highest standards in medical device safety. Notified bodies, instrumental in the certification process, have faced a considerable backlog due to the overwhelming demand for CE mark certifications and re-certifications. To alleviate this pressure, regulatory authorities have granted an extension, providing these bodies with additional time to handle the growing workload.

Why Manufacturers Should Stay Vigilant

While the extension offers a breathing space for notified bodies, it is imperative for medical device manufacturers not to interpret this as a relaxation of regulations. Compliance with these regulations remains non-negotiable. Manufacturers must continue to meet the stringent criteria outlined in the EU regulations to ensure that their products are safe and effective for patients. Cutting corners or delaying compliance measures not only risks regulatory repercussions but also jeopardizes patient safety and trust.

Proactive Measures: Partnering with Experts

In the face of these regulatory changes, it is crucial for medical device manufacturers to take proactive steps. Rather than viewing the extension as an opportunity to procrastinate, manufacturers should use this time wisely to fortify their compliance processes. One of the most effective ways to do this is by partnering with experienced medical device consultancies, such as Patient Guard.

Why Patient Guard?

Patient Guard is a leading medical device consultancy renowned for its expertise in regulatory compliance. By collaborating with consultants who understand the intricacies of the regulations, manufacturers can streamline their certification processes. Engaging with experts not only helps in navigating the complexities of compliance but also ensures that manufacturers stay ahead of the rush. Being proactive in seeking guidance can make a significant difference, enabling manufacturers to obtain certifications efficiently and effectively.

Upholding Excellence in Medical Device Manufacturing

The extension of Article 120 in the EU Regulation 2017/745 and EU Regulation 2017/746 is a testament to the EU’s dedication to patient safety and product quality. However, for manufacturers, this extension should serve as a reminder rather than a reprieve. By proactively adhering to the regulations and seeking expert guidance from consultancies like Patient Guard, manufacturers can not only meet the compliance standards but also contribute to a healthcare landscape where patient safety and quality are paramount. Remember, compliance is not just a legal obligation; it’s a commitment to excellence, integrity, and the well-being of patients worldwide.

Share this content


Leave a Comment

Your email address will not be published. Required fields are marked *